GO:0047390 glycerophosphocholine cholinephosphodiesterase activity: Mechanism, Genes and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0047390 describes the molecular function glycerophosphocholine cholinephosphodiesterase activity, which catalyzes the hydrolysis of sn-glycero-3-phosphocholine to choline phosphate, glycerol, and H+.
The enzyme is a Zn2+-requiring phosphodiesterase that also hydrolyzes p-nitrophenylphosphocholine, linking it to choline metabolism and phospholipid turnover [1,2].
In brain, the enzyme exists as glycosylphosphatidylinositol-anchored forms that can be released by specific phospholipases, suggesting a role in membrane-associated signaling [7,8].
Altered phospholipid metabolites, including those related to glycerophosphocholine, have been observed in postmortem Alzheimer's disease brain, implicating this activity in neurodegeneration.
Bacterial homologs such as the enzyme from Streptomyces sanglieri have been purified and cloned, providing tractable models for mechanistic and structural studies.
Divalent metal ions, especially Zn2+, are critical for catalysis, and the active site has been probed by chemical modification and metal substitution studies [2,5].

Description

Glycerophosphocholine cholinephosphodiesterase activity (GO:0047390) is a molecular function that catalyzes the cleavage of sn-glycero-3-phosphocholine into choline phosphate, glycerol, and a proton. This reaction sits at the intersection of phospholipid catabolism and choline salvage, making it relevant to membrane homeostasis and neurotransmitter synthesis. The enzyme was first characterized in mammalian brain as a Zn2+-dependent phosphodiesterase that also accepts p-nitrophenylphosphocholine as a substrate. Subsequent work showed that the brain enzyme is membrane-associated, with a glycosylphosphatidylinositol anchor that can be cleaved by specific phospholipases, suggesting a dynamic regulation at the cell surface [7,8]. Because glycerophosphocholine is a major osmolyte and phospholipid metabolite, its hydrolysis may influence diverse cellular processes, from osmoregulation to lipid signaling. Researchers studying neurodegeneration, choline metabolism, or bacterial phospholipid remodeling will find this activity a useful entry point for mechanistic and therapeutic investigations [3,4].

glycerophosphocholine cholinephosphodiesterase activity At A Glance

GO ID GO:0047390
GO term glycerophosphocholine cholinephosphodiesterase activity
Ontology molecular_function
Synonym L-3-glycerylphosphinicocholine cholinephosphohydrolase activity; sn-glycero-3-phosphocholine cholinephosphohydrolase activity
Major function Hydrolysis of sn-glycero-3-phosphocholine to choline phosphate, glycerol, and H+
Cofactor Zn2+ (zinc-dependent enzyme)
Subcellular location Membrane-associated; glycosylphosphatidylinositol-anchored forms in brain
Representative source Bovine brain, ox brain, Streptomyces sanglieri

What Is GO:0047390?

According to the Gene Ontology, GO:0047390 is defined as the catalysis of the reaction: sn-glycero-3-phosphocholine + H2O = choline phosphate + glycerol + H+. In other words, it is a hydrolase activity that removes the choline phosphate headgroup from glycerophosphocholine, releasing glycerol and a proton. The term is also known by synonyms such as L-3-glycerylphosphinicocholine cholinephosphohydrolase activity and sn-glycero-3-phosphocholine cholinephosphohydrolase activity. This activity is distinct from phospholipases that cleave intact phospholipids; instead, it acts on the water-soluble phosphodiester glycerophosphocholine.

Why Is glycerophosphocholine cholinephosphodiesterase activity Important in Cell Biology?

Glycerophosphocholine cholinephosphodiesterase activity is important because it controls the breakdown of glycerophosphocholine, a central metabolite in phospholipid turnover and choline homeostasis. By releasing choline phosphate, the enzyme contributes to the pool of choline available for acetylcholine synthesis and for regeneration of phosphatidylcholine, a major membrane phospholipid [1,2]. In the brain, the enzyme is enriched in myelin and exists as glycosylphosphatidylinositol-anchored forms that can be released by phospholipases, suggesting roles in membrane remodeling and cell signaling [7,8]. Alterations in phospholipid metabolites, including glycerophosphocholine, have been reported in Alzheimer's disease brain, pointing to a possible link between this activity and neurodegeneration. Bacterial homologs are also of interest for biotechnological applications and as models for understanding phosphodiesterase mechanism.
Regulates choline phosphate and glycerol levels derived from glycerophosphocholine.
Contributes to choline availability for acetylcholine and phosphatidylcholine synthesis.
Membrane-associated and glycosylphosphatidylinositol-anchored forms allow rapid regulation at the cell surface.
Enzyme activity can be released from membranes by glycosylphosphatidylinositol-specific phospholipases, linking it to signaling events.
Zn2+ dependence makes it sensitive to metal homeostasis and potential metal-based inhibition.
Altered phospholipid metabolites in Alzheimer's disease brain suggest a role in neurodegeneration.
Bacterial enzyme from Streptomyces sanglieri provides a model for structural and kinetic studies.
Potential target for modulating choline metabolism in cancer and neurological disorders [3,4].

What Happens During glycerophosphocholine cholinephosphodiesterase activity?

Substrate recognition and binding
In simple terms: The enzyme grabs a specific molecule called glycerophosphocholine.
The enzyme binds sn-glycero-3-phosphocholine, positioning the phosphodiester bond for cleavage. The active site accommodates the glycerophosphocholine headgroup, and the enzyme also accepts the synthetic substrate p-nitrophenylphosphocholine, which is used in activity assays. The binding likely involves interactions with the choline moiety and the glycerol backbone, as suggested by substrate specificity studies [1,6].
Catalytic hydrolysis
In simple terms: Water is used to split the molecule into choline phosphate and glycerol.
The enzyme catalyzes the hydrolysis of the phosphodiester bond, yielding choline phosphate, glycerol, and a proton. This reaction is dependent on a Zn2+ ion at the active site, which activates a water molecule for nucleophilic attack [1,2]. The pH optimum and kinetic parameters have been characterized for the bovine brain enzyme.
Metal ion requirement
In simple terms: Zinc helps the enzyme work properly.
The enzyme requires Zn2+ for activity, and other divalent metal ions can interact with the enzyme, often inhibiting or substituting for zinc. The active site contains essential residues that coordinate the metal ion, as shown by chemical modification and metal substitution experiments.
Membrane association and release
In simple terms: The enzyme can be attached to the cell membrane and then set free by specific enzymes.
In brain, the enzyme exists in membrane-bound forms, including glycosylphosphatidylinositol-anchored variants that can be released by glycosylphosphatidylinositol-specific phospholipases [7,8]. This release mechanism may regulate enzyme activity and localization in response to cellular signals.

Key Genes Involved in GO:0047390 glycerophosphocholine cholinephosphodiesterase activity

The following genes and proteins are directly implicated in glycerophosphocholine cholinephosphodiesterase activity or its regulation, based on published biochemical and molecular studies.
GeneMajor RoleResearch Relevance
GPC-PDE (bovine brain)Encodes the Zn2+-dependent glycerophosphocholine cholinephosphodiesteraseModel for enzyme purification and characterization [1,6]
GPC-PDE (ox brain)Zn2+-glycerophosphocholine cholinephosphodiesteraseStudied for divalent metal ion interactions
GPC-PDE (rat brain)Membrane-bound enzymeUsed to study glycosylphosphatidylinositol anchoring
GPC-PDE (human brain)Enzyme activity in postmortem tissueLinked to Alzheimer's disease phospholipid changes
Streptomyces sanglieri gpcPDEBacterial glycerophosphocholine cholinephosphodiesteraseCloned and expressed for biotechnological applications
GPI-PLCGlycosylphosphatidylinositol-specific phospholipase CReleases the enzyme from membranes
GPI-PLDGlycosylphosphatidylinositol-specific phospholipase DAlso releases the enzyme from membranes
Zn2+ transportersMaintain cellular zinc homeostasisAffect enzyme activity via metal availability
Choline kinasePhosphorylates choline to choline phosphateOpposite direction of the pathway
Phosphatidylcholine phospholipase DGenerates phosphatidic acid and cholineRelated to choline metabolism
Acetylcholine transferaseUses choline for acetylcholine synthesisDownstream of choline phosphate release
Glycerophosphocholine phosphodiesterase (other isoforms)Potential additional isoformsMay exist in different tissues
p-nitrophenylphosphocholine hydrolaseSynthetic substrate activityUsed for enzyme assays
GPI-anchored proteinsMembrane attachmentRegulate enzyme localization
Myelin basic proteinMyelin componentCo-localizes with enzyme in myelin
Choline transporterUptake of cholineIndirectly affects substrate availability

How Is glycerophosphocholine cholinephosphodiesterase activity Regulated?

The activity of glycerophosphocholine cholinephosphodiesterase is regulated at multiple levels. The enzyme is membrane-associated and can be released from membranes by glycosylphosphatidylinositol-specific phospholipases, providing a rapid mechanism to modulate its localization and activity. Divalent metal ions, particularly Zn2+, are essential for catalysis, and changes in cellular zinc homeostasis can influence enzyme function. Additionally, the enzyme's activity may be affected by post-translational modifications and interactions with membrane lipids, as suggested by its association with myelin. In brain, the enzyme's levels and activity may change in pathological conditions such as Alzheimer's disease, where phospholipid metabolism is altered.

glycerophosphocholine cholinephosphodiesterase activity and Human Disease

GeneDisease / BiologyPotential Experimental Model
GPC-PDE (human)Alzheimer's diseaseHuman postmortem brain tissue, iPSC-derived neurons
GPC-PDE (bovine)NeurodegenerationBovine brain membrane preparations [1,6]
Streptomyces sanglieri gpcPDEBacterial phospholipid metabolismRecombinant expression in E. coli
GPI-PLCMembrane signalingKnockout mice or cell lines
Zn2+ transportersMetal homeostasis disordersZinc supplementation or chelation in cell culture
Alzheimer's disease and neurodegeneration
Alterations in phospholipid metabolites, including glycerophosphocholine, have been observed in postmortem brain from patients with Alzheimer's disease, suggesting that glycerophosphocholine cholinephosphodiesterase activity may be involved in the disease process. The enzyme's role in choline metabolism could affect acetylcholine synthesis and membrane integrity, both of which are impaired in Alzheimer's disease [2,3].
Cancer and cell proliferation
Choline metabolism is reprogrammed in many cancers, and enzymes that regulate glycerophosphocholine levels may influence tumor growth. Although direct evidence for glycerophosphocholine cholinephosphodiesterase in cancer is limited, the bacterial homolog and mammalian enzyme provide models to study choline salvage pathways that could be targeted in cancer.
Bacterial infections and biotechnology
The bacterial enzyme from Streptomyces sanglieri has been purified and cloned, and it may play a role in bacterial phospholipid metabolism. This enzyme could be a target for antibacterial strategies or a tool for biotransformation of glycerophosphocholine.

From glycerophosphocholine cholinephosphodiesterase activity-Related Genes to Experimental Models

Research QuestionSuitable Model
What is the catalytic mechanism of the enzyme?Recombinant bacterial enzyme from Streptomyces sanglieri
How does Zn2+ affect enzyme activity?Site-directed mutagenesis of metal-binding residues
What is the role of GPI anchoring in localization?GPI-PLC treatment of brain membranes
Does the enzyme contribute to Alzheimer's disease?Human postmortem brain samples and iPSC-derived neurons
Can the enzyme be targeted for cancer therapy?Cancer cell lines with altered choline metabolism
How is the enzyme regulated by phospholipases?Knockout of GPI-PLC in cell lines

How to Study the glycerophosphocholine cholinephosphodiesterase activity Process

MethodWhat It MeasuresTypical Application
Colorimetric assay with p-nitrophenylphosphocholineEnzyme activityKinetic studies and inhibitor screening
Radioactive substrate assayHydrolysis of sn-glycero-3-phosphocholineTissue distribution and subcellular localization
SDS-PAGE and Western blotProtein size and identityPurification and characterization
GPI-PLC treatmentRelease of GPI-anchored enzymeMembrane anchoring studies
Site-directed mutagenesisRole of specific residuesActive site mapping
Metal ion substitutionEffect of divalent cationsCofactor requirement
qRT-PCRGene expression levelsTissue-specific expression
ImmunohistochemistryTissue localizationBrain distribution
Enzyme activity assays
Enzyme activity is typically measured using sn-glycero-3-phosphocholine or the chromogenic substrate p-nitrophenylphosphocholine, monitoring the release of choline phosphate or p-nitrophenol. These assays are used to determine kinetic parameters, pH optima, and metal ion requirements.
Protein purification and characterization
The enzyme has been purified from bovine brain and Streptomyces sanglieri using chromatographic techniques, followed by SDS-PAGE and mass spectrometry to identify the protein [1,4]. Purification allows detailed biochemical characterization, including determination of molecular weight and subunit composition.
Molecular cloning and recombinant expression
The bacterial gene encoding glycerophosphocholine cholinephosphodiesterase has been cloned and expressed in E. coli, enabling site-directed mutagenesis and structural studies. Recombinant expression also facilitates large-scale production for biotechnological applications.
Membrane release and GPI-anchor analysis
The release of the enzyme from brain membranes by glycosylphosphatidylinositol-specific phospholipases can be studied using enzymatic treatments followed by activity assays and Western blotting. This approach helps determine the type of membrane anchoring and regulation.

How CRISPR Can Be Used to Study GO:0047390 glycerophosphocholine cholinephosphodiesterase activity

Knockout

CRISPR knockout of the gene encoding glycerophosphocholine cholinephosphodiesterase can be used to eliminate enzyme activity in cell lines or animal models, allowing researchers to study its role in choline metabolism and membrane homeostasis [1,2]. Knockout models may reveal compensatory pathways and help validate the enzyme as a therapeutic target.

Point Mutation

Introducing point mutations in the active site residues, such as those coordinating Zn2+, can help dissect the catalytic mechanism and metal dependence [2,5]. These mutants can be expressed in cells to assess effects on enzyme activity and downstream metabolites.

Knock-in

Knock-in of tagged versions of the enzyme, such as FLAG or GFP fusions, enables live-cell imaging and proteomic analysis of interacting partners [7,8]. Tagged knock-in models can also be used to track the enzyme's localization and release from membranes.

Overexpression

Overexpression of the enzyme in cell lines or transgenic animals can lead to increased glycerophosphocholine hydrolysis and altered choline phosphate levels, providing a gain-of-function model to study downstream effects [1,4]. Overexpression may also be used to produce recombinant enzyme for structural studies.

How EDITGENE Supports glycerophosphocholine cholinephosphodiesterase activity Research

Researchers studying glycerophosphocholine cholinephosphodiesterase activity-related genes often need to determine whether a candidate gene is causally involved in choline metabolism, membrane remodeling, or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to create precise cellular and animal models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for glycerophosphocholine cholinephosphodiesterase activity research.

Frequently Asked Questions About glycerophosphocholine cholinephosphodiesterase activity

It is a molecular function (GO:0047390) that catalyzes the hydrolysis of sn-glycero-3-phosphocholine to choline phosphate, glycerol, and H+.
The enzyme is encoded by genes in mammals and bacteria, such as the bovine brain enzyme and the Streptomyces sanglieri gpcPDE [1,4].
Zinc is a required cofactor; the enzyme is a Zn2+-dependent phosphodiesterase, and metal ions can modulate its activity [2,5].
It can be released from membranes by glycosylphosphatidylinositol-specific phospholipases, and its activity depends on zinc availability [7,8].
Alterations in phospholipid metabolites, including glycerophosphocholine, have been observed in Alzheimer's disease brain, suggesting a possible link.
It uses sn-glycero-3-phosphocholine and can also hydrolyze p-nitrophenylphosphocholine.
Activity is commonly measured using colorimetric or radioactive assays with p-nitrophenylphosphocholine or sn-glycero-3-phosphocholine [1,6].
It is membrane-associated, with glycosylphosphatidylinositol-anchored forms in brain myelin.
Yes, a novel enzyme from Streptomyces sanglieri has been purified, characterized, and cloned.
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models can be generated to study its function and regulation [1,2,4].

Conclusion

Glycerophosphocholine cholinephosphodiesterase activity (GO:0047390) is a Zn2+-dependent phosphodiesterase that hydrolyzes glycerophosphocholine to choline phosphate, glycerol, and H+. Its membrane association, GPI anchoring, and regulation by phospholipases highlight its dynamic role in choline metabolism and membrane remodeling [7,8]. The enzyme has been linked to phospholipid changes in Alzheimer's disease and is a subject of interest in bacterial biotechnology [3,4]. With the availability of CRISPR models and biochemical assays, researchers can now dissect its precise functions and explore its therapeutic potential.

References

  1. 1. Sok DE et al.. 1992. Characterization of a Zn(2+)-requiring glycerophosphocholine cholinephosphodiesterase possessing p-nitrophenylphosphocholine phosphodiesterase activity.. Biochem J 286 ( Pt 2)(Pt 2):435-40 PMID: 1326942
  2. 2. Sok DE. 1998. Active site of brain Zn2+-glycerophosphocholine cholinephosphodiesterase and regulation of enzyme activity.. Neurochem Res 23(8):1061-7 PMID: 9704595
  3. 3. Nitsch R et al.. 1991. Alterations of phospholipid metabolites in postmortem brain from patients with Alzheimer's disease.. Ann N Y Acad Sci 640:110-3 PMID: 1663712
  4. 4. Sugimori D et al.. 2014. Purification, characterization, molecular cloning, and extracellular production of a novel bacterial glycerophosphocholine cholinephosphodiesterase from Streptomyces sanglieri.. J Biosci Bioeng 117(4):422-30 PMID: 24211038
  5. 5. Lee KJ et al.. 1997. Interaction of divalent metal ions with Zn(2+)-glycerophosphocholine cholinephosphodiesterase from ox brain.. Neurochem Res 22(12):1471-6 PMID: 9357012
  6. 6. Sok DE. 1996. Properties of a Zn(2+)-glycerophosphocholine cholinephosphodiesterase from bovine brain membranes.. Neurochem Res 21(10):1193-9 PMID: 8923480
  7. 7. Sok DE et al.. 1994. Brain myelin-bound Zn(2+)-glycerophosphocholine cholinephosphodiesterase is a glycosylphosphatidylinositol-anchored enzyme of two different molecular forms.. Neurochem Res 19(1):97-103 PMID: 8139771
  8. 8. Lee JY et al.. 1998. Enzymatic release of Zn2+-glycerophosphocholine cholinephosphodiesterase from brain membranes by glycosylphosphatidylinositol-specific phospholipases and its regulation.. Neurochem Res 23(6):899-905 PMID: 9572679
Contact Us
*
*
*
*
How did you hear about us: